GCG and Insulin resistance: No alteration of blood glucose by linagliptin is in good agreement with the previous findings that the significant improvement of insulin resistance by GLP-1 or GLP-1 receptor analogue in DS rats did not change blood glucose levels in DS rats [58], and seems to be explained by the fact that DS rats exhibit insulin resistance but no fasting hyperglycemia [36-39].